SCHEMBL9885084

SCHEMBL9885084

CCC(C)Nc1nc(N)ncc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 6/20 0.51
TLR8 Q9NR97 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
LRRK2 Q5S007 1/20 0.38
JAK1 P23458 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
HSP90AA1 P07900 1/20 0.37
CYP3A4 P08684 1/20 0.37
THRB P10828 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HIF1A Q16665 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.36
LATS1 O95835 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL250475 1.00 NUDT1 (0.51) NUDT1TLR8TLR7LRRK2JAK1
SCHEMBL218367 1.00 NUDT1 (0.51) NUDT1TLR8TLR7LRRK2JAK1
SCHEMBL12692509 0.85 NUDT1 (0.53) NUDT1TLR8TLR7JAK1L3MBTL1
SCHEMBL9925932 0.82 BCL6 (0.46) NUDT1TLR8TLR7LRRK2JAK1
SCHEMBL9885019 0.82 BCL6 (0.46) NUDT1TLR8TLR7LRRK2L3MBTL1
SCHEMBL218364 0.82 BCL6 (0.46) NUDT1TLR8TLR7LRRK2JAK1
SCHEMBL12692517 0.82 BCL6 (0.46) NUDT1TLR8TLR7LRRK2L3MBTL1
SCHEMBL15354459 0.82 BCL6 (0.46) NUDT1TLR8TLR7LRRK2L3MBTL1
SCHEMBL9925942 0.82 BCL6 (0.46) NUDT1TLR8TLR7LRRK2JAK1
SCHEMBL22866186 0.80 GLP1R (0.40) LRRK2JAK1L3MBTL1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120245169-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS INTELLIKINE LLC 2012-09-27 US disclosed
US-8193182-B2 Substituted isoquinolin-1(2H)-ones, and methods of use thereof INTELLIKINE, INC. (US) 2012-06-05 US disclosed
US-20090312319-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS INTELLIKINE 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312319-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS PIK3CA, PIK3CG, PIK3CB NUDT1 791/4885TLR8 3751/4885TLR7 3302/4885
US-20120245169-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS PIK3CA, PIK3CG, PIK3CB NUDT1 791/4885TLR8 3751/4885TLR7 3302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.